GNRH1 and ovarian carcinoma: Three drug-resistant ovarian cancer cell lines (SKOV-3, ES-2, NIH:OVCAR-3) and one drug-resistant endometrial cancer cell line (HEC-1A) were incubated with 12.5 μM CB-LHRH’.